RWPA
AVXL icon

Richard W. Paul & Associates’s Anavex Life Sciences AVXL Stock Holding History

Richard W. Paul & Associates’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-132
Closed -$1.42K – 345
2024
Q4 		$1.42K Hold
132
– – ﹤0.01% 441
2024
Q3 		$750 Hold
132
– – ﹤0.01% 476
2024
Q2 		$557 Hold
132
– – ﹤0.01% 473
2024
Q1 		$672 Hold
132
– – ﹤0.01% 479
2023
Q4 		$1.23K Hold
132
– – ﹤0.01% 443
2023
Q3 		$865 Sell
132
-43
-25% -$342 ﹤0.01% 453
2023
Q2 		$1.42K Sell
175
-120
-41% -$1.03K ﹤0.01% 452
2023
Q1 		$2.53K Hold
295
– – ﹤0.01% 424
2022
Q4 		$2.73K Buy
+295
New +$3.15K ﹤0.01% 409

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return